A New Era in Oncology: Tennessee's $20 Million Leap into Radiopharmaceutical Research
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Metastatic Colon Adenocarcinoma
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB11967
Binimetinib
1
Terminated
1
DB11718
Encorafenib
1
Terminated
1
DB06186
Ipilimumab
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Terminated
1
DB08896
Regorafenib
1
Active Not Recruiting
1
DB08937
TAS-102
1
Completed
1
DB09343
Tipiracil
1
Completed
1
DB00432
Trifluridine
1
Completed
1
DB12001
Abemaciclib
1 / 2
Active Not Recruiting
1
DB15676
Balstilimab
1 / 2
Recruiting
1
DB00112
Bevacizumab
1 / 2
Recruiting
1
DB16651
Botensilimab
1 / 2
Recruiting
1
DB01373
Calcium
1 / 2
Recruiting
1
DB00002
Cetuximab
1 / 2
Active Not Recruiting
1
DB00002
Cetuximab
1 / 2
Recruiting
1
DB11718
Encorafenib
1 / 2
Recruiting
1
DB00544
Fluorouracil
1 / 2
Recruiting
1
DB00650
Leucovorin
1 / 2
Recruiting
1
DB11596
Levoleucovorin
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Recruiting
2
DB00526
Oxaliplatin
1 / 2
Recruiting
1
DB11105
Benzalkonium
2
Active Not Recruiting
1
DB00112
Bevacizumab
2
Active Not Recruiting
1
DB00002
Cetuximab
2
Recruiting
1
DB11718
Encorafenib
2
Recruiting
1
DB00762
Irinotecan
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Recruiting
1
DB01269
Panitumumab
2
Active Not Recruiting
1
DB08896
Regorafenib
2
Active Not Recruiting
1
DB12048
Savolitinib
2
Terminated
1
DB08937
TAS-102
2
Active Not Recruiting
2
DB08937
TAS-102
2
Not Yet Recruiting
1
DB04485
Thymidine
2
Active Not Recruiting
1
DB09343
Tipiracil
2
Active Not Recruiting
2
DB09343
Tipiracil
2
Not Yet Recruiting
1
DB00072
Trastuzumab
2
Not Yet Recruiting
1
DB00432
Trifluridine
2
Active Not Recruiting
2
DB00432
Trifluridine
2
Not Yet Recruiting
1
DB11652
Tucatinib
2
Not Yet Recruiting
1